Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.1M | $72.0M | $92.0M | $120M | $117M | $220M | $297M | $361M | $446M | $517M |
| Revenue growth | — | 10.6% | 27.9% | 30.8% | -2.4% | 86.8% | 35.1% | 21.8% | 23.5% | 16.0% |
| Gross profit | — | — | — | — | — | — | $176M | $230M | $298M | $363M |
| Gross margin | — | — | — | — | — | — | 59.2% | 63.6% | 66.9% | 70.1% |
| Operating income | -$28.8M | -$26.5M | -$22.2M | -$15.1M | -$35.4M | -$81.9M | -$41.1M | -$85.8M | $16.1M | $57.8M |
| Operating margin | -44.3% | -36.9% | -24.2% | -12.6% | -30.1% | -37.3% | -13.9% | -23.8% | 3.6% | 11.2% |
| Net income | — | — | -$23.0M | -$12.6M | -$34.9M | -$75.6M | -$36.6M | -$74.4M | $24.1M | $66.4M |
| Net margin | — | — | -25.0% | -10.5% | -29.7% | -34.4% | -12.3% | -20.6% | 5.4% | 12.8% |
| EPS (diluted) | -$1.09 | -$0.91 | -$0.62 | -$0.27 | -$0.66 | -$1.11 | -$0.51 | -$1.02 | $0.31 | $0.82 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$28.0M | -$23.9M | -$13.5M | -$3.23M | -$9.71M | -$31.6M | $7.54M | $44.2M | $75.1M | $136M |
| Capital expenditures | $4.21M | $1.75M | $1.87M | $2.76M | $2.84M | $5.38M | $8.55M | $9.96M | $11.3M | $9.68M |
| Free cash flow | -$32.2M | -$25.7M | -$15.4M | -$5.99M | -$12.5M | -$37.0M | -$1.01M | $34.3M | $63.8M | $127M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $59.2M | $33.9M | $78.0M | $159M | $349M | $173M | $154M | $216M | $239M | $363M |
| Total assets | $101M | $78.7M | $121M | $275M | $457M | $1.19B | $1.16B | $1.11B | $1.30B | $1.41B |
| Total liabilities | $41.5M | $41.4M | $40.9M | $35.8M | $35.9M | $91.3M | $81.2M | $70.8M | $124M | $96.4M |
| Long-term debt | $24.9M | $24.9M | $23.9M | $694K | $810K | $0.00 | — | — | — | — |
| Shareholders' equity | $59.6M | $37.2M | $79.8M | $239M | $421M | $1.10B | $1.08B | $1.04B | $1.18B | $1.31B |
| Retained earnings | -$180M | -$211M | -$234M | -$247M | -$282M | -$357M | -$394M | -$468M | -$444M | -$378M |
| Shares (wtd avg diluted) | 33.8M | 33.8M | 40.9M | 46.1M | 53.2M | 67.9M | 71.5M | 72.6M | 78.2M | 80.6M |
Every figure is extracted from VERACYTE, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.